Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample

(1) Background: The COVID-19 outbreak has created pressure in people’s daily lives, further threatening public health. Thus, it is important to assess people’s perception of stress during COVID-19 for both research and practical purposes. The Perceived Stress Scale (PSS) is one of the most widely used instruments to measure perceived stress; however, previous validation studies focused on specific populations, possibly limiting the generalization of results. (2) Methods: This study tested the psychometric properties of three versions of the Chinese Perceived Stress Scale (CPSS-14, CPSS-10, and CPSS-4) in the Chinese general population during the COVID-19 pandemic. A commercial online survey was employed to construct a nationally representative sample of 1133 adults in Mainland China (548 males and 585 females) during a one-week period. (3) Results: The two-factor (positivity and negativity) solution for the three versions of the CPSS showed a good fit with the data. The CPSS-14 and CPSS-10 had very good reliability and the CPSS-4 showed acceptable reliability. Scores on all three versions of the CPSS were significantly correlated in the expected direction with health-related variables (e.g., depression, anxiety, and perceived COVID-19 risk), supporting the concurrent validity of the CPSS. (4) Conclusions: All three versions of the CPSS appear to be appropriate for use in research with samples of adults in the Chinese general population under the COVID-19 crisis. The CPSS-10 and CPSS-14 both have strong psychometric properties, but the CPSS-10 would have more utility because it is shorter than the CPSS-14. However, the CPSS-4 is an acceptable alternative when administration time is limited.

Download Full-text

Prevalence and sociodemographic associations of common mental disorders in a nationally representative sample of the general population of Greece

BMC Psychiatry ◽

10.1186/1471-244x-13-163 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 52

Author(s):

Petros Skapinakis ◽

Stefanos Bellos ◽

Sotirios Koupidis ◽

Ilias Grammatikopoulos ◽

Pavlos N Theodorakis ◽

...

Keyword(s):

General Population ◽

Mental Disorders ◽

Representative Sample ◽

Common Mental Disorders ◽

Nationally Representative ◽

Of Greece

Download Full-text

Bereavement Experience in the General Population: Incidence, Consequences, and Coping in a National Sample of Japan

OMEGA - Journal of Death and Dying ◽

10.2190/1ywv-r8v5-k6dw-6390 ◽

2004 ◽

Vol 48 (2) ◽

pp. 137-147 ◽

Cited By ~ 4

Author(s):

Satoshi Shimai

Keyword(s):

Mental Health ◽

Depressive Symptoms ◽

General Population ◽

Representative Sample ◽

Public Mental Health ◽

National Sample ◽

Point Of View ◽

Department Of Health ◽

Nationally Representative ◽

And Coping

The present study was conducted to investigate the actual status of bereavement experience in the general population of Japan. Data were collected via questionnaires from a nationally representative sample of Japanese aged 12 years and older from the National Survey of Trends of Health and Welfare by the Department of Health and Welfare of Japan in 2000. The number of valid questionnaires was 32,022 (15,217 male, 16,597 female, and 208 unidentified). Among them, 1082 people (410 males and 672 females) answered that they had experienced the death of a person close to them within the last month. This means that approximately 5% of the general population had experienced bereavement within the month prior to the survey. The bereavement experience caused modest but substantial elevation in depressive symptoms. The middle-aged population most commonly experienced bereavement, and women were more likely to be affected seriously by bereavement. These results suggested that appropriate mental health strategies for bereaved people are important from a public mental health point of view.

Download Full-text

Multimorbidity in Latin America and the Caribbean: a systematic review and meta-analysis

BMJ Open ◽

10.1136/bmjopen-2021-050409 ◽

2021 ◽

Vol 11 (7) ◽

pp. e050409

Author(s):

Alessandra M Huaquía-Díaz ◽

Tarick S Chalán-Dávila ◽

Rodrigo M Carrillo-Larco ◽

Antonio Bernabe-Ortiz

Keyword(s):

Systematic Review ◽

General Population ◽

Latin American ◽

Representative Sample ◽

Data Extraction ◽

Meta Analysis ◽

Eligibility Criteria ◽

Pooled Prevalence ◽

The Caribbean ◽

Nationally Representative

ObjectiveTo estimate the pooled prevalence of multimorbidity (≥2 non-communicable diseases in the same individual) among adults of the general population of Latin American and the Caribbean (LAC).DesignSystematic review and meta-analysis.Data sourcesMEDLINE, Embase, Global Health, Scopus and LILACS up to 1 July 2020.Eligibility criteria for selecting studiesThe outcome was the prevalence of multimorbidity. Reports were selected whether they enrolled adult individuals (age ≥18 years) from the general population.Data extraction and synthesisReviewers extracted relevant data and assessed risk of bias independently. A random-effects meta-analysis was conducted to report pooled prevalence estimates of multimorbidity; pooled estimates by pre-specified subgroups (eg, national studies) were also pursued.ResultsFrom 5830 results, we selected 28 reports, mostly from Brazil and 16 were based on a nationally representative sample. From the 28 selected reports, 26 were further included in the meta-analysis revealing a pooled multimorbidity prevalence of 43% (95% CI: 35% to 51%; I2: 99.9%). When only reports with a nationally representative sample were combined, the pooled prevalence was 37% (95% CI: 27% to 47%; I2: 99.9%). When the ascertainment of multimorbidity was based on self-reports alone, the pooled prevalence was 40% (95% CI: 31% to 48%; I2: 99.9%); this raised to 52% (95% CI: 33% to 70%; I2: 99.9%) for reports including self-reported and objective diagnosis.ConclusionsOur results complement and advance those from global efforts by incorporating much more reports from LAC. We revealed a larger presence of multimorbidity in LAC than previously reported.PROSPERO registration numberCRD42020196177.

Download Full-text